Entero Therapeutics, Inc. (ENTO)
NASDAQ: ENTO · Real-Time Price · USD
0.4101
-0.0700 (-14.58%)
At close: Apr 1, 2025, 4:00 PM
0.4570
+0.0469 (11.43%)
After-hours: Apr 1, 2025, 7:35 PM EDT

Entero Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Apr '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
235182928
Upgrade
Market Cap Growth
-71.30%-44.22%-71.77%-38.97%6.51%29.74%
Upgrade
Enterprise Value
2-04111828
Upgrade
Last Close Price
0.414.20122.586069.0140740.0443680.04
Upgrade
Debt / Equity Ratio
0.000.230.32-0.13-0.240.35
Upgrade
Quick Ratio
0.021.190.590.670.430.66
Upgrade
Current Ratio
5.341.581.370.770.510.80
Upgrade
Return on Equity (ROE)
-21.61%-497.87%---3305.91%-333.90%
Upgrade
Return on Assets (ROA)
-25.22%-159.97%-91.98%-286.81%-151.38%-112.57%
Upgrade
Return on Capital (ROIC)
-31.39%-244.72%---784.82%-168.30%
Upgrade
Buyback Yield / Dilution
-1324.34%-836.57%----
Upgrade
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q